高级检索
当前位置: 首页 > 详情页

Longitudinal circulating tumor DNA (ctDNA) analysis predicts response and reveals the resistance mechanisms of ensartinib in ALK plus NSCLC patients (pts) progressed on crizotinib: Updated analysis of a phase II clinical trial

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP) ◇ 自然指数

单位: [1]Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, State Key Lab Oncol South China,Collaborat Innova, Guangzhou, Peoples R China [2]Hangzhou Repugene Technol, Hangzhou, Peoples R China [3]Zhejiang Univ, Affiliated Hosp 1, Coll Med, Thorac Dis Ctr,Dept Resp Dis, Hangzhou, Peoples R China [4]Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Dept Med Oncol,Affiliated Canc Hosp, Nanjing, Peoples R China [5]Fujian Med Univ, Fujian Prov Canc Hosp, Dept Thorac Oncol, Canc Hosp, Fuzhou, Peoples R China [6]Hunan Canc Hosp, Dept Med Oncol Chest, Changsha, Peoples R China [7]Beijing Canc Hosp, Dept Thorac Oncol, Beijing, Peoples R China [8]Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pulm Med, Beijing, Peoples R China [9]Zhengzhou Univ, Affiliated Canc Hosp, Henan Prov Canc Hosp, Resp Dept Internal Med, Zhengzhou, Peoples R China [10]Zhejiang Canc Hosp, Thorac Med Oncol, Hangzhou, Peoples R China [11]Nanjing Univ, Jinling Hosp, Div Resp Med, Sch Med, Nanjing, Peoples R China [12]Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China [13]Qingdao Univ, Affiliated Hosp, Dept Oncol, Qingdao, Peoples R China [14]Sichuan Univ, West China Hosp, Canc Ctr, Dept Thorac Oncol, Chengdu, Peoples R China [15]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China [16]Xiamen Univ, Affiliated Hosp 1, Dept Med Oncol, Sch Med,Teaching Hosp,Fujian Med Univ,Canc Hosp, Xiamen, Peoples R China [17]Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Med Oncol, Beijing, Peoples R China [18]Univ Sci & Technol China, Anhui Prov Hosp, Resp Med, Affiliated Hosp 1, Hefei, Peoples R China [19]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China [20]Sun Yat Sen Univ, Affiliated Hosp 1, Pulm & Crit Care Med, Guangzhou, Peoples R China [21]Guangzhou Med Univ, Resp Med Dept, State Key Lab Resp Dis,Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis,Guangzhou Inst Resp Hl, Guangzhou, Peoples R China [22]Jilin Univ, Hosp 1, Canc Ctr, Changchun, Peoples R China [23]First Peoples Hosp Foshan, Dept Head & Neck & Thorac Med Oncol, Foshan, Peoples R China [24]China Med Univ, Oncol Med, Hosp 1, Shenyang, Peoples R China [25]Gen Hosp Northern Theater Command, Oncol Dept, Shenyang, Peoples R China [26]Yunnan Canc Hosp, Dept Thorac Surg 2, Kunming, Yunnan, Peoples R China [27]Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, PET CT Ctr, Beijing, Peoples R China [28]Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, Natl Clin Res Ctr Canc,Natl Canc Ctr,Dept Diagnos, Beijing, Peoples R China [29]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Radiol, Beijing, Peoples R China [30]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Pulm Oncol, Beijing, Peoples R China [31]Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, Natl Canc Ctr,Dept Diagnost Radiol,Natl Clin Res, Beijing, Peoples R China [32]Betta Pharmaceut Co Ltd, Hangzhou, Peoples R China [33]Xcovery Holdings, Palm Beach Gardens, FL USA
出处:
ISSN:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, State Key Lab Oncol South China,Collaborat Innova, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:432 今日访问量:0 总访问量:413 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)